The effect of intracarotid injection of serotonin (5-HT) on internal carotid artery flow and oxygen availability (02a) of the cerebral cortex was studied in 10 baboons. Vasoconstriction occurred in the vascular bed of the territory supplied by the injected artery. After one middle cerebral artery was occluded the vasoconstrictor effect of 5-HT was more pronounced, particularly in the non-ischaemic hemisphere. The capacity of the cerebral vessels to provide collateral blood flow was reduced in both ischaemic and non-ischaemic areas of brain. As a result of focal cerebral ischaemia, 5-HT may accumulate in the brain and contribute to the progression of infarction.
The functional importance of the biogenic amine serotonin (5-hydroxytryptamine, has been emphasized in several extensive reviews (Woolley, 1962;  Garattini and Valzelli, 1965; Mantegazza, 1966) . Serotonin is known to be a potent cerebral vasoconstrictor (Raynor, McMurtry, and Pool, 1961; Bohr, Goulet, and Taquini, 1961;  Karlsberg, Elliott, and Adams, 1963) , and it may be an important aetiological factor in migraine (Lance and Anthony, 1968) . Until the present investigation, the possible relationship of 5-HT to the pathophysiology of cerebrovascular disease has been largely concerned with the occurrence of vasospasm after subarachnoid haemorrhage and of vascular changes associated with cerebral trauma (Echlin, 1965; Brawley, Strandness, and Kelly, 1968; Simeone, Ryan, and Cotter, 1968; Arutiunov, Baron, and Majorova, 1970; Wilkins and Odom, 1970) . In addition to its vasoconstrictor action, 5-HT depresses the reticular formation, cardiorespiratory centres and the cerebral cortex, and causes cerebral oedema (Marrazzi and Hart, 1955; Gaddum and Vogt, 1956; Bulle, 1957; Costa and Rinaldi, 1958; Monnier, 1960;  1 Supported by Grant No. NS 09287-01 from the National Institute of Neurological Diseases and Stroke. 724 Majno and Palade, 1961; Domer and Longo, 1962; Osterholm and Pyenson, 1969) .
Changes in the microcirculation of the leptomeningeal vessels have been observed by several investigators after occlusion of a major cerebral artery Meyer and Denny-Brown, 1957; Meyer, 1958) . Waltz and Sundt (1967) noted that, after occlusion of the middle cerebral artery in the squirrel monkey, scattered foci of pallor of the cerebral cortex developed which later coalesced. A fluctuating decrease in the calibre of the leptomeningeal vessels was seen in over 900 of their preparations. They mentioned that 5-HT might possibly be released to account for the vasoconstriction and pallor of the cortex.
The hypothesis that altered 5-HT metabolism in ischaemic brain might contribute to the spread of infarction was supported by the work of Bell, Sundt, and Nofzinger (1967) who permanently occluded the middle cerebral artery in the squirrel monkey and applied 5-HT topically.
They reported that, in general, the vessels in the ischaemic area were more sensitive to the vasoconstrictive action of 5-HT than the arteries of the non-ischaemic hemisphere. However, in some of the experiments conducted by Bell, the vessels of the non-ischaemic hemisphere were equally sensitive and, in some instances, more sensitive to the action of 5-HT than the vessels in the ischaemic zones. Waltz and Sundt (1967) also observed some constriction of the arteries and arterioles of the non-ischaemic hemisphere, which was attributed to autoregulation during increases in blood pressure.
Altered vasomotor reactivity in regions of the brain remote from an ischaemic area may be an important consideration in determining the severity of cerebral infarction, since such factors will influence the competence of the collateral circulation. For example, cerebral blood flow has been reported to be depressed in the nonischaemic cerebral hemisphere in patients with unilateral cerebral infarction, a phenomenon termed diaschisis (Von Monakov, 1914; H0edt-Rasmussen and Skinh0j, 1964; Skinh0j, 1965; Meyer, Shinohara, Kanda, Fukuuchi, Ericsson, and Kok, 1970) . It is possible that increased sensitivity to vasoconstrictive stimuli of vessels remote from a localized area of cerebral infarction due to release of 5-HT may be a factor in the aetiology of diaschisis.
The present experiments were designed to measure the effect of intracarotid injection of 5-HT on cerebral collateral blood flow after unilateral cerebral ischaemia produced by temporary occlusion and release of the middle cerebral artery in the baboon.
METHOD
Ten baboons, averaging 6 kg in weight, were anaesthetized with intravenous pentobarbitone, 30 mg/kg, and 0-4 mg atropine was given intramuscularly. Supplemental pentobarbitone was given as required to maintain continuous anaesthesia. Tracheostomy was performed, and the animals were given gallamine triethiodide (Flaxedil); controlled respiration enabled constant levels of expired CO2 to be maintained (Harvard model 607 respirator). Both femoral arteries and one femoral vein were cannulated with polyethylene catheters in order to measure arterial blood pressure and 5-HT content of the arterial blood and to permit intravenous infusion. A midline cervical incision was made to expose the cervical vessels, and small polythylene catheters for injection of 5-HT were inserted into both internal carotid arteries via the facial artery. The transorbital approach described by Hudgins and Garcia (1970) Two gated sine wave electromagnetic flowmeter probes were placed around both common carotid arteries. Both external carotid arteries were ligated, and flow in the common carotid artery was used for measuring internal carotid artery flow. Pulsatile flow was recorded on the Grass polygraph.
The 5-HT content of whole blood was measured using an autoanalytical procedure developed in this laboratory ELECTROENCEPHALOGRAPHY Generalized slow wave activity, more pronounced in the injected hemisphere, occurred after almost all unilateral intracarotid injections of 5-HT. Activity usually returned to normal within 10 to 15 minutes. The induced focal cerebral ischaemia did not exaggerate this effect of intracarotid injection of 5-HT on the EEG.
HAEMODYNAMIC CHANGE DURING AND IMMEDI-ATELY AFTER MIDDLE CEREBRAL ARTERY OCCLU-SION Mean flow in the ipsilateral internal carotid artery decreased significantly during the 30 minute period of middle cerebral occlusion then increased significantly above pre-occlusion values immediately after the vessel was unclamped. Internal carotid flow of the nonischaemic hemisphere did not alter. 02a in the territory of the occluded middle cerebral artery decreased promptly and significantly. In a few instances after the clamp was released hyperoxia was noted in areas of previously ischaemic cortex. However, the mean 02a in the ischaemic parietal cortex remained significantly reduced (at 85% of the steady state level) 25 minutes after release of occlusion (P<0-05). Significant increase in mean O2a of the left frontal region during parietal ischaemia presumably reflected the development of collateral flow. Cortical 02a did not alter in the non-ischaemic hemisphere.
EFFECT OF 5-HT BEFORE CEREBRAL ISCHAEMIA Injection of 5-HT (20 p,g/kg/min) into the internal carotid artery significantly decreased ipsilateral internal carotid flow to both hemispheres (Table 1A) . There was no significant difference between the two vessels in the amount of decrease. Flow always increased in the carotid vessel contralateral to that injected, presumably because it acts as a collateral channel. However, such collateral flow was significantly less in the internal carotid artery of the hemisphere which had been prepared for the middle cerebral artery occlusion (P < 0 05).
The reproducibility of the response to repeated injections into the same artery (Table 1B) indicates that neither tachyphylaxis nor sensitization of the carotid vessels developed.
Changes in cortical O2a were similar to those of carotid flow. 02a of the ipsilateral, frontal, and parietal cortex decreased significantly and consistently with repeated injection of 5-HT (Table 2 ). In accordance with observed increases in carotid flow, 02a of the parietal cortices contralateral to the injected hemispheres increased towards the end of the period of observation (see Figs 3B and 4B), although there was an initial decrease in 02a of the non-ischaemic parietal cortex, probably due to movement of 5-HT to the non-injected hemisphere via the circle of Willis (see Fig. 3B ).
EFFECT OF 5-HT AFTER CEREBRAL ISCHAEMIA When 5-HT was injected to the ischaemic hemisphere ipsilateral carotid artery flow decreased significantly and, although the decrease was more prolonged, the values noted were not significantly different from those obtained before ischaemia. On these occasions collateral flow in the contralateral internal carotid artery was reduced and delayed (Fig. 1B) . Changes identical with those of carotid flow were observed in 02a of the ischaemic and the contralateral nonischaemic parietal cortex, except that there was the same initial decrease in contralateral parietal 02a that was observed before ischaemia (see Fig. 3A and B) . However, frontal cortical 02a of the ischaemic hemisphere did decrease more rapidly and to a greater degree than before ischaemia upon ipsilateral 5-HT injection (see Fig. 5 ).
When 5-HT was injected to the non-ischaemic hemisphere ipsilateral carotid flow decreased to a significantly greater degree compared with before ischaemia. On these occasions significant collateral flow was not observed in the contralateral carotid artery (Fig. 2B) . There was also an earlier greater and more sustained reduction noted in ipsilateral parietal 02a compared with before ischaemia (Fig. 4A) . Again on these occasions contralateral parietal 02a of the ischaemic cortex was also significantly reduced, unlike before ischaemia when hyperoxia was observed (Fig. 4B) .
MEASUREMENT OF 5-HT IN FEMORAL ARTERIAL AND
CEREBRAL VENOUS BLOOD Concentrations of 5-HT in the cerebral venous (V) and femoral arterial (A) blood were measured after eight injections before ischaemia and eight injections after ischaemia in order to determine the 'washout' of 5-HT from the brain. The A-V differences for 5-HT are shown in Table 3 . A negative A-V difference was apparent during the socalled steady state both before and after ischaemia. The mean negative A-V difference in the steady state is due to the fact that the 5-HT levels were not determined in a true steady state (Karlsberg et al., 1963; Grimson, Robinson, and Danford, Tindall, and Greenfield, 1969; Deshmukh and Harper, 1971) . Constriction of the internal carotid artery after 5-HT injection was noted on arteriography in two of these studies (Grimson et al., 1969; Deshmukh and Harper, 1971) . Mchedlishvili (1969) demonstrated a direct vasoconstrictor effect by 5-HT on the isolated carotid artery in the dog in the absence of an autonomic nerve supply. Topical application of 5-HT has also been reported to cause constriction of the pial arteries (Raynor et al., 1961) . The studies of Grimson et al. (1969) indicate that total intracranial cerebrovascular resistance may be increased by unilateral intracarotid injection of 5-HT. In our preparations, when 5-HT was injected into one internal carotid artery, flow in the opposite vessel increased, presumably due to its action as a collateral vessel to replenish the territory supplied by the injected vessel. However, this capacity to provide collateral flow was less marked in the carotid artery of the hemisphere prepared for middle cerebral artery occlusion, possibly due to the operative preparation itself which necessitates enucleation of the orbital contents and ligation of the ophthalmic artery. The opposite ophthalmic artery is left intact and may serve as a collateral vessel despite ligature of the external carotid artery, since extracranial tissues were not surgically removed. This may account for the observed differences in collateral flow. An alternative explanation might be that 5-HT when injected to the opposite hemisphere passes to the extracranial vasculature via the circle of Willis and patent right ophthalmic artery. Should 5-HT increase extracranial blood flow as suggested by Deshmukh and Harper (1971) , this could also account for the increased collateral flow in the right carotid artery over the left. However, this mechanism seems less important since cortical flow increased with carotid flow (Fig. 3B ). In the same way, since regional blood flow changes measured with the brain implanted oxygen electrodes corresponded well with the carotid flow changes, we do not believe extracranial contamination was a practical problem in our studies. The validity of polarographic electrodes used in our experiments to measure 02a of brain tissue as an indication of local circulatory changes has been discussed in previous papers (Meyer, Fang, and Denny-Brown, 1954; Clark, Misrahy, and Fox, 1958; Halsey and Clark, 1970) . A decrease in cortical O2a measured with the electrodes in the hemisphere on the injected side was noted after intracarotid injection of 5-HT. The percentage reduction in O2a from steady state levels was less than expected from the percentage reduction of internal carotid artery flow, possibly due to the depressant effect of 5-HT at the levels injected on oxygen consumption (such an effect would tend to obscure the fall in cerebral 02a caused by decreased regional cerebral blood flow) (Halsey and Clark, 1970) or 5-HT may have a selectively greater vasoconstrictor effect on the larger branches of the internal carotid distribution (Lende, 1960) . Deshmukh and Harper (1971) simultaneously measured mean regional cerebral blood flow determined from 133Xenon clearance curves and internal carotid artery flow with electromagnetic flowmeters. In a small number of experiments, mean regional cerebral blood flow did not change significantly after intracarotid 5-HT injection despite a decrease in the internal carotid flow associated with marked constriction of the internal carotid artery. The bolus method requires at least 10 minutes to measure cerebral blood flow, so that some of the rapid changes measured here may not have been measured for technical reasons. The reduction of cortical O2a levels in our series of experiments suggest that vasoconstriction occurs in the vascular bed of the territory supplied by the artery injected with 5-HT in agreement with other studies (Grimson et al., 1969) .
EFFECT OF 5-HT INJECTION TO ISCHAEMIC HEMI-SPHERE There was no convincing difference in the reduction of carotid flow after ipsilateral 5-HT injection before and after ischaemia. Similar observations were made by measuring parietal 02a of the ischaemic cortex, although for both measurements the reduction in flow from steady state values was prolonged. Bell et al. (1967) observed significant increases in the vasoconstrictor response of the cerebral microvasculature to topically applied 5-HT in areas of brain rendered ischaemic by permanent occlusion of the middle cerebral artery. They concluded that cerebral ischaemia sensitized these vessels to the vasoconstrictor effects of 5-HT. In the present experiments, O2a in the ischaemic cortex returned to only 85% of the steady state value after the left middle cerebral artery was unclamped, suggesting reduced regional blood flow. Yet when 5-HT was injected to the ischaemic hemisphere after middle cerebral occlusion the percentage reduction in ipsilateral parietal 02a, apart from being prolonged, was identical with preocclusion values. This suggests the possibility of increased vasoconstrictor effect of 5-HT on vessels in the ischaemic region. However, convincing alteration in response of the vessels in the ischaemic region to 5-HT is shown when 5-HT is injected into the non-ischaemic hemisphere (Fig. 4B ). Either movement of 5-HT to the ischaemic hemisphere via the circle of Willis, or recirculating 5-HT, reduced O2a of the ischaemic cortex by a vasoconstrictor effect which was not demonstrated before occlusion. Although not absolute, the results of this study tend to support the report of Bell et al. (1967) that cerebral ischaemia increases the response of the cerebral microvasculature in the ischaemic area to the vasoconstrictor action of 5-HT.
EFFECT OF 5-HT INJECTION TO NONISCHAEMIC HEMISPHERE The reduction of internal carotid blood flow and cortical O2a of the nonischaemic hemisphere after injecting 5-HT was more pronounced after ischaemia. There was neither evidence of tachyphylaxis nor sensitization of the cerebral vessels to 5-HT (Table 2) . Since blood pressure and end-tidal CO2 content were constant, these observations suggest an increased vasoconstrictor effect of 5-HT on the cerebral vessels in the non-ischaemic hemisphere, presumably resulting in some way from ischaemia of the opposite hemisphere. Since the right hemisphere was neither ischaemic nor anoxic, as judged by carotid flow and cortical 02a levels, four possible explanations are offered to account for this apparent increased vasoconstrictor effect of 5-HT on the cerebral vessels of the intact hemisphere:
1. The greater reduction of flow in the ischaemic hemisphere produced by 5-HT injection after middle cerebral artery occlusion may be due to the decreased capacitance of the vessels in the ischaemic left parietal zone to provide collateral flow, as seen in Figs 2B and 4B. 2. A central and neurogenically mediated alteration in vasomotor tone and reactivity to humoral elements secondary to localized cerebral ischaemia.
3. Ischaemia of one hemisphere causes increased levels of free 5-HT in the unaffected areas of brain, cerebrospinal fluid (CSF), or circulating blood which enhance the vasoconstrictor effect of injected free 5-HT.
4. Alteration in brain tissue, CSF, or circulating blood levels of some other substance or substances as a result of brain ischaemia which augments the vasoconstrictor properties of 5-HT.
The extraordinarily rapid and much greater vasoconstrictor effect of injected 5-HT seen in this instance after induced brain ischaemia serves to dismiss the first hypothesis, since mechanical reduction of collateral flow in the ischaemic hemisphere would be expected to have a more delayed effect. Strong support is given to the other three possibilities by the observation that 5-HT injected to the ischaemic hemisphere before middle cerebral artery occlusion causes increased collateral flow in the non-ischaemic hemisphere which was not as increased or sustained when similar injections of 5-HT were made after ischaemia (see Figs lB and 3B). In addition, there was an increased vasoconstrictor effect of 5-HT on collateral vessels in the ischaemic hemisphere itself (Fig. 5 ). This loss of collateral capacitance could best be explained by the vasoactivity of elevated 5-HT levels, or increases in levels of some other vasoconstrictive factor in brain, CSF, or blood alone, or in combination with a central neurogenically mediated effect as suggested. The subject of central neurogenic control of cerebral vasoactivity is ill-understood and controversial (Rosenblum, 1971) . However, alteration of some such control cannot be excluded as a partial explanation of some of the findings of this study.
Collateral flow is initially a passive phenomenon governed by intravascular pressure differences throughout the circulation (Symon, Ishikawa, and Meyer, 1963) . Therefore, factors that will impair collateral flow must be: obstruction of the vascular lumen-for example, by endothelial swelling or aggregation of blood elements; compression of vessels from without by oedema of perivascular glial cells; or increased tone of the vessel wall itself. In our experiments, some of these conditions were already in evidence after removal of occlusion, since regional blood flow in the ischaemic area returned to only 85% of its preocclusion value. Bell et al. (1967) found increased reactivity of ischaemic vessels to the vasoconstrictor action of topically applied 5-HT. Supportive evidence from their study, particularly the altered reactivity of ischaemic vessels (Fig. 4B) , serves to implicate 5-HT as one factor responsible for increased tone of the ischaemic vessels. Since 5-HT contributes to impairment of collateral flow, it seems warranted to consider this substance further in the aetiology of poor perfusion (Ames, Wright, Kowada, Thurston, and Majno, 1968) after cerebral infarction.
It is well known that cerebral vessels in nonischaemic areas of brain can act as collateral channels for blood flow to the territory supplied by an occluded vessel. What has emerged from this study is that the capacity of these same cerebral vessels to provide collateral flow may be impaired by ischaemia.
Release of 5-HT from the platelets in cerebral blood and possible accumulation of 5-HT in brain tissue after ischaemic anoxia due to damage to the blood-brain barrier, have been demonstrated already in another series of experiments in this laboratory (Welch, Meyer, Teraura, Hashi, and Shinmaru, 1972) . Evidence to support the latter was obtained in the present experiments from measurement of femoral arterial and cerebral venous differences for 5-HT after injection into the carotid artery. Before middle cerebral artery occlusion, a significant cerebral wash-out of 5-HT was measured (Table  5 ). After occlusion of the middle cerebral artery this significant wash-out was no longer present, indicating either increased movement of 5-HT from blood into brain caused by ischaemic damage to the blood-brain barrier or else delayed wash-out of 5-HT from the cerebral vasculature due to slowing of capillary and venous blood.
Free 5-HT accumulated in brain tissue from the blood after cerebral ischaemia could fully preempt receptor sites. The monamine oxidases present in brain, which are reduced by ischaemic anoxia (Pau §escu, Lugojan, and Pau §escu, 1970) , could be insufficient to metabolize the excess 5-HT (Brodie and Reid, 1968) . Brain tissue levels of 5-HT elevated in this way move into CSF to produce diffuse effects on brain function. Studies of 5-HT levels in the blood of patients with cerebrovascular disease have been contradictory, in that increased, normal, and decreased levels of 5-HT were found (Krieger, Kolodny, and Warner, 1964; Wilkins, Silver, and Odom, 1966; Berzin, Auna, and Brezhinskiy, 1969) . Another explanation for increased 5-HT in nonischaemic cerebral cortex, brain-stem, and CSF after cerebral infarction may be that compensatory metabolism of the serotonergic system increases as a result of 5-HT release into areas of brain damage. Osterholm and Ryenson (1969) reported this in cats after experimentally induced cerebral trauma.
The role of altered 5-HT metabolism in the pathophysiology of cerebral infarction is supported by elevated levels of 5-HT found in the CSF of patients with thromboembolic and haemorrhagic cerebrovascular disease (Southern and Christoff, 1962; Misra, Singh, and Bhargava, 1967; Berzin et al., 1969) . Stoica and colleagues (Stoica and Nash, 1966; Stoica, Pau §escu, and Trandafirescu, 1968) demonstrated increased reactivity of the cerebral vessels to cold stress in patients with cerebrovascular disease and related this observation to changes in 5-HT levels in the blood of these patients. Their findings seem particularly pertinent to our present study. Berzin et al. (1969) proceeded even further with this concept, relating the severity of the clinical condition after various types of stroke to increases in 5-HT blood levels in patients with cerebrovascular disease.
That altered 5-HT metabolism may be implicated in the aetiology of diaschisis can be only speculative. It does not seem unreasonable, however, to hypothesize that increased sensitivity to vasoconstrictive stimuli of the vessels in areas remote from localized cerebral ischaemia may be partially responsible for some reduction of cerebral blood flow to areas of brain not involved in the ischaemic process.
The present study indicates that altered 5-HT metabolism may affect the adequacy of the collateral circulation and may be an active factor in progressive reduction of cerebral blood flow in both the ischaemic and non-ischaemic cerebral hemispheres of the brain. The role that 5-HT and other neurotransmitters may play in the genesis of cerebral oedema, neuronal depression, and diaschisis is being investigated further.
